These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26369664)

  • 1. Virologic suppression and mortality of patients who migrate for HIV care in the province of British Columbia, Canada, from 2003 to 2012: a retrospective cohort study.
    Lima VD; Goldberg N; Lourenço L; Chau W; Hogg RS; Guillemi S; Barrios R; Montaner JS
    BMC Health Serv Res; 2015 Sep; 15():376. PubMed ID: 26369664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional and temporal trends in migration among people living with HIV/AIDS in British Columbia, 1993-2005.
    Lima VD; Druyts E; Montaner JS; Hogg RS
    Can J Public Health; 2010; 101(1):44-9. PubMed ID: 20364538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marijuana use and viral suppression in persons receiving medical care for HIV-infection.
    Okafor CN; Zhou Z; Burrell LE; Kelso NE; Whitehead NE; Harman JS; Cook CL; Cook RL
    Am J Drug Alcohol Abuse; 2017 Jan; 43(1):103-110. PubMed ID: 27398989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a rural/urban gap in the quality of HIV care for treatment-naïve HIV-positive individuals initiating antiretroviral therapy in British Columbia?
    MacKenzie LJ; Hull MW; Samji H; Lima VD; Yip B; Zhang W; Lourenço L; Colley G; Hogg RS; Montaner JSG
    AIDS Care; 2017 Oct; 29(10):1218-1226. PubMed ID: 28472896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Where Are They Now? Assessing if Persons Returned to HIV Care Following Loss to Follow-Up by Public Health Case Workers Were Engaged in Care in Follow-Up Years.
    Udeagu CN; Shah S; Misra K; Sepkowitz KA; Braunstein SL
    AIDS Patient Care STDS; 2018 May; 32(5):181-190. PubMed ID: 29750551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effectiveness of initiating non-nucleoside reverse transcriptase inhibitor- versus ritonavir-boosted protease inhibitor-based antiretroviral therapy: implications for first-line therapy choice in resource-limited settings.
    Lima VD; Hull M; McVea D; Chau W; Harrigan PR; Montaner JS
    J Int AIDS Soc; 2016; 19(1):20978. PubMed ID: 27499064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in mortality rates and causes of death in a population-based cohort of persons living with and without HIV from 1996 to 2012.
    Eyawo O; Franco-Villalobos C; Hull MW; Nohpal A; Samji H; Sereda P; Lima VD; Shoveller J; Moore D; Montaner JS; Hogg RS;
    BMC Infect Dis; 2017 Feb; 17(1):174. PubMed ID: 28241797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The opioid crisis is driving mortality among under-served people living with HIV in British Columbia, Canada.
    Salters KA; Parent S; Nicholson V; Wang L; Sereda P; Pakhomova TE; Kibel M; Chau W; Closson K; Parashar S; Barrios R; Montaner JSG; Hogg RS
    BMC Public Health; 2021 Apr; 21(1):680. PubMed ID: 33832472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site migration in seeking care services from multiple providers is associated with worse clinical outcomes among HIV-infected individuals in Washington, DC.
    Jia Y; Sengupta D; Opoku J; Wu C; Griffin A; West T; Samala R; Shaikh I; Pappas G
    AIDS Care; 2014; 26(11):1346-51. PubMed ID: 24797410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Treatment as Prevention on the HIV Epidemic in British Columbia, Canada.
    Lima VD; Brumme ZL; Brumme C; Sereda P; Krajden M; Wong J; Guillemi SA; Henry B; Hogg RS; Barrios R; Montaner JSG;
    Curr HIV/AIDS Rep; 2020 Apr; 17(2):77-87. PubMed ID: 32124189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cohort profile: the Comparative Outcomes And Service Utilization Trends (COAST) Study among people living with and without HIV in British Columbia, Canada.
    Eyawo O; Hull MW; Salters K; Samji H; Cescon A; Sereda P; Lima VD; Nosyk B; Whitehurst DGT; Lear SA; Montaner JSG; Hogg RS;
    BMJ Open; 2018 Jan; 8(1):e019115. PubMed ID: 29331972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparities in multimorbidity and mortality among people living with and without HIV across British Columbia's health regions: a population-based cohort study.
    Nanditha NGA; Zheng G; Tafessu HM; McLinden T; Bratu A; Kopec J; Hogg RS; Montaner JSG; Lima VD
    Can J Public Health; 2021 Dec; 112(6):1030-1041. PubMed ID: 34462891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of the COVID-19 pandemic on HIV treatment gap lengths and viremia among people living with HIV British Columbia, Canada, during the COVID-19 pandemic: Are we ready for the next pandemic?
    Munasinghe LL; Yin W; Nathani H; Toy J; Sereda P; Barrios R; Montaner JSG; Lima VD
    Soc Sci Med; 2024 Jun; 350():116920. PubMed ID: 38703468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overdose mortality is reducing the gains in life expectancy of antiretroviral-treated people living with HIV in British Columbia, Canada.
    St-Jean M; Dong X; Tafessu H; Moore D; Honer WG; Vila-Rodriguez F; Sereda P; Hogg RS; Patterson TL; Salters K; Barrios R; Montaner JSG; Lima VD
    Int J Drug Policy; 2021 Oct; 96():103195. PubMed ID: 33773878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress towards the United Nations 90-90-90 and 95-95-95 targets: the experience in British Columbia, Canada.
    Lima VD; St-Jean M; Rozada I; Shoveller JA; Nosyk B; Hogg RS; Sereda P; Barrios R; Montaner JSG
    J Int AIDS Soc; 2017 Nov; 20(3):. PubMed ID: 29130644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A province-wide HIV initiative to accelerate initiation of treatment-as-prevention and virologic suppression in British Columbia, Canada: a population-based cohort study.
    Nanditha NGA; Dong X; Tafessu HM; Wang L; Lu M; Barrios R; Montaner JSG; Lima VD
    CMAJ Open; 2022; 10(1):E27-E34. PubMed ID: 35042692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excess burden of age-associated comorbidities among people living with HIV in British Columbia, Canada: a population-based cohort study.
    Nanditha NGA; Paiero A; Tafessu HM; St-Jean M; McLinden T; Justice AC; Kopec J; Montaner JSG; Hogg RS; Lima VD
    BMJ Open; 2021 Jan; 11(1):e041734. PubMed ID: 33419911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of scaling-up combination antiretroviral therapy on patterns of mortality among HIV-positive persons in British Columbia, Canada.
    Lima VD; Eyawo O; Ma H; Lourenço L; Chau W; Hogg RS; Montaner JS
    J Int AIDS Soc; 2015; 18(1):20261. PubMed ID: 26449273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A text messaging intervention to improve retention in care and virologic suppression in a U.S. urban safety-net HIV clinic: study protocol for the Connect4Care (C4C) randomized controlled trial.
    Christopoulos KA; Riley ED; Tulsky J; Carrico AW; Moskowitz JT; Wilson L; Coffin LS; Falahati V; Akerley J; Hilton JF
    BMC Infect Dis; 2014 Dec; 14():718. PubMed ID: 25551175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geographic variation in the costs of medical care for people living with HIV in British Columbia, Canada.
    Enns B; Min JE; Panagiotoglou D; Montaner JSG; Nosyk B;
    BMC Health Serv Res; 2019 Sep; 19(1):626. PubMed ID: 31481056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.